Sanchez, Pablo J |
| Active, not recruiting | 3 | 1824 | US | Liberal Cell Transfusion, Restricted red cell transfusion | NICHD Neonatal Research Network, National Heart, Lung, and Blood Institute (NHLBI), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Infant, Newborn, Diseases, Infant, Extremely Low Birth Weight, Infant, Small for Gestational Age, Bronchopulmonary Dysplasia (BPD), Anemia | 01/20 | 08/25 | | |
| Active, not recruiting | 3 | 800 | US | Hydrocortisone, Placebo | NICHD Neonatal Research Network, National Center for Research Resources (NCRR), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Heart, Lung, and Blood Institute (NHLBI), National Center for Advancing Translational Sciences (NCATS) | Infant, Newborn, Infant, Small for Gestational Age, Infant, Very Low Birth Weight, Infant, Premature, Bronchopulmonary Dysplasia | 09/20 | 01/25 | | |
| Terminated | 3 | 827 | US | Caffeine Citrate, Placebo | NICHD Neonatal Research Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Apnea of Prematurity | 01/23 | 03/23 | | |
| Active, not recruiting | 3 | 1160 | US | budesonide (Pulmicort nebulizing suspension)., Pulmicort nebulizing suspension., surfactant (poractant alfa;Curosurf), poractant alfa;Curosurf | NICHD Neonatal Research Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Bronchopulmonary Dysplasia (BPD), Respiratory Distress Syndrome, Prematurity; Extreme, Neonatal | 09/24 | 12/26 | | |
| Active, not recruiting | 3 | 836 | US | Active Treatment, Expectant Management | NICHD Neonatal Research Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Infant, Premature, Patent Ductus Arteriosus, Infant, Newborn, Diseases, Patent Ductus Arteriosus After Premature Birth | 04/25 | 05/27 | | |
| Active, not recruiting | 2 | 66 | US | Milrinone, Milrinone Lactate Injection, Primacor, Placebo (5% Dextrose), D5W | NICHD Neonatal Research Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Congenital Diaphragmatic Hernia, Persistent Pulmonary Hypertension of the Newborn, Hypoxemic Respiratory Failure, Pulmonary Hypoplasia | 09/24 | 03/25 | | |
NCT06061081: A Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in in Treatment-Naive Adults Living With HIV-1 |
|
|
| Suspended | 2 | 26 | Europe, US, RoW | VH3739937, Placebo | ViiV Healthcare | HIV Infections | 11/24 | 11/24 | | |
NCT04318587: Assessment of Donor Derived Cell Free DNA and Utility in Lung Transplantation |
|
|
| Terminated | N/A | 40 | US | Allosure | Pablo Sanchez, CareDx | Lung Transplant Failure and Rejection | 12/22 | 12/23 | | |
| Not yet recruiting | N/A | 2433 | US | Higher Platelet Transfusion Threshold, Liberal Transfusion Threshold, Lower Platelet Transfusion Threshold, Restrictive Transfusion Threshold | NICHD Neonatal Research Network, National Heart, Lung, and Blood Institute (NHLBI) | Thrombocytopenia, Neonatal, Platelet Transfusion, Infant, Newborn, Diseases, Infant, Extremely Low Birth Weight, Infant, Small for Gestational Age, Thrombosis | 01/31 | 04/31 | | |
| Recruiting | N/A | 1700 | US | Phototherapy lights | NICHD Neonatal Research Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Hyper Bilirubinemia, Premature Infant | 07/25 | 07/25 | | |
NCT05547698: A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation |
|
|
| Recruiting | N/A | 228 | Europe, US | Off-pump lung transplantation, Venoarterial ECMO lung transplantation | Mayo Clinic | Lung Transplant | 09/25 | 09/25 | | |
| Recruiting | N/A | 924 | US | Quantitative polymerase chain reaction (qPCR) assay for detection of Treponema pallidum, Aptima Treponema pallidum transcription-mediated amplification (TMA) assay for detection of Treponema pallidum, Center for Disease Control (CDC) Sexually Transmitted Infections (STI) 2021 Treatment Guidelines for diagnosis of syphilis | The University of Texas Health Science Center, Houston, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Syphilis | 11/27 | 11/27 | | |
NCT00063063: Generic Database of Very Low Birth Weight Infants |
|
|
| Recruiting | N/A | 80000 | US | | NICHD Neonatal Research Network, National Center for Research Resources (NCRR), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature | 03/30 | 03/30 | | |
| Recruiting | N/A | 68000 | US | | NICHD Neonatal Research Network, National Center for Research Resources (NCRR), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature | 03/30 | 03/30 | | |
Pedrosa, Ivan |
NCT06076538: PET/MR for Characterization of Renal Masses (RMs) |
|
|
| Recruiting | N/A | 97 | US | 2-Deoxy-2-[18F]fluoroglucose Positron Emission Tomography/Magnetic Resonance Imaging, FDG PET/MR | University of Texas Southwestern Medical Center, Radiological Society of North America | Renal Tumor, Renal Cell Carcinoma, Renal Tumor, Benign | 06/28 | 06/28 | | |
Woroniecki, Robert |
| Recruiting | N/A | 1200 | Canada, US | Kidney Biopsy | University of Michigan, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The NephCure Foundation | Minimal Change Disease (MCD), Membranous Nephropathy, Glomerulosclerosis, Focal Segmental | 06/26 | 06/26 | | |
Sambandam, Kamal |
| Recruiting | N/A | 1200 | Canada, US | Kidney Biopsy | University of Michigan, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The NephCure Foundation | Minimal Change Disease (MCD), Membranous Nephropathy, Glomerulosclerosis, Focal Segmental | 06/26 | 06/26 | | |
Jain, Raksha |
| Recruiting | 4 | 100 | US | Denosumab | University of Texas Southwestern Medical Center | Cystic Fibrosis | 07/27 | 07/27 | | |
| Recruiting | 1/2 | 40 | US | 4D-710 | 4D Molecular Therapeutics | Cystic Fibrosis Lung | 12/26 | 01/30 | | |
| Completed | N/A | 956 | US | Parental Status | University of Pittsburgh, Cystic Fibrosis Foundation, National Heart, Lung, and Blood Institute (NHLBI) | Cystic Fibrosis, Parenthood Status | 08/24 | 08/24 | | |
| Recruiting | N/A | 146 | US | Parenthood | University of Pittsburgh, Cystic Fibrosis Foundation, National Heart, Lung, and Blood Institute (NHLBI) | Cystic Fibrosis, Parenthood Status | 02/30 | 02/31 | | |
| Active, not recruiting | N/A | 350 | US | Stool tests, Stool-based Fecal Immunochemical Testing (FIT) test and Stool-based DNA test (Cologuard) test. | University of Washington, the Collaborative Health Studies Coordinating Center, Cystic Fibrosis Foundation | Cystic Fibrosis, Colorectal Cancer, Adenoma | 03/25 | 06/25 | | |
| Active, not recruiting | N/A | 285 | US | | Amalia Magaret, University of Texas, National Jewish Health, Cystic Fibrosis Foundation | Pregnancy Related, Cystic Fibrosis | 12/26 | 12/26 | | |
Keller, Ashley |
| Recruiting | 4 | 730 | Canada, US | Beta-lactam antibiotic, β-lactam, Aminoglycoside, AG | Chris Goss, University of Washington, Medical University of South Carolina, Cystic Fibrosis Foundation | Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | 11/26 | 11/26 | | |
| Recruiting | 4 | 100 | US | Denosumab | University of Texas Southwestern Medical Center | Cystic Fibrosis | 07/27 | 07/27 | | |
| Recruiting | 1/2 | 40 | US | 4D-710 | 4D Molecular Therapeutics | Cystic Fibrosis Lung | 12/26 | 01/30 | | |
| Recruiting | 1 | 40 | US | Gallium nitrate, Ga, GaN3O9, IV gallium, ganite | Chris Goss, Cystic Fibrosis Foundation | Nontuberculous Mycobacterium Infection | 06/25 | 06/25 | | |
| Completed | N/A | 956 | US | Parental Status | University of Pittsburgh, Cystic Fibrosis Foundation, National Heart, Lung, and Blood Institute (NHLBI) | Cystic Fibrosis, Parenthood Status | 08/24 | 08/24 | | |
CHEC-SC, NCT03350828: CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes |
|
|
| Active, not recruiting | N/A | 5000 | US | | Nicole Hamblett, Cystic Fibrosis Foundation | Cystic Fibrosis | 12/26 | 12/26 | | |
| Recruiting | N/A | 146 | US | Parenthood | University of Pittsburgh, Cystic Fibrosis Foundation, National Heart, Lung, and Blood Institute (NHLBI) | Cystic Fibrosis, Parenthood Status | 02/30 | 02/31 | | |
| Active, not recruiting | N/A | 350 | US | Stool tests, Stool-based Fecal Immunochemical Testing (FIT) test and Stool-based DNA test (Cologuard) test. | University of Washington, the Collaborative Health Studies Coordinating Center, Cystic Fibrosis Foundation | Cystic Fibrosis, Colorectal Cancer, Adenoma | 03/25 | 06/25 | | |
NCT06504589: A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators |
|
|
| Recruiting | N/A | 400 | US | | Nicole Hamblett, Washington University School of Medicine, Florida State University, University of North Carolina, Chapel Hill, University of Toronto, Cystic Fibrosis Foundation | Cystic Fibrosis | 08/29 | 08/29 | | |
| Active, not recruiting | N/A | 285 | US | | Amalia Magaret, University of Texas, National Jewish Health, Cystic Fibrosis Foundation | Pregnancy Related, Cystic Fibrosis | 12/26 | 12/26 | | |
Key, Kelli |
NCT04483414: 68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer |
|
|
| Withdrawn | 2 | 50 | US | 68Ga PSMA-11 injection, Positron Emission Tomography/Computed Tomography, PET/CT | Dana Mathews | Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Metastatic to Bone | 04/23 | 04/23 | | |
NCT04006522: 89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma |
|
|
| Recruiting | 2 | 40 | US | 89Zr-DFO-Atezolizumab, Positron Emission Tomography/Computed Tomography, PET/CT | James Brugarolas | Renal Cell Carcinoma | 07/25 | 07/26 | | |
NCT04989959: [18F]PT2385 PET/CT in Patients with Renal Cell Carcinoma |
|
|
| Recruiting | 1 | 35 | US | [18F]PT2385, Positron Emission Tomography/Computed Tomography, PET/CT, Biopsy | Orhan Kemal Oz | Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma | 08/26 | 08/27 | | |
NCT05002465: Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer |
|
|
| No Longer Available | N/A | | US | 68Ga-PSMA-11, Positron Emission Tomography/Computed Tomography, PET/CT | Dana Mathews | Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Recurrent | | | | |
NCT04493411: Noninvasive Detection and Assessment of Therapy Response in Multiple Myeloma Using Whole-Body MRI |
|
|
| Active, not recruiting | N/A | 40 | US | WBMRI, Positron Emission Tomography/Computed Tomography (PET/CT) | University of Texas Southwestern Medical Center | Multiple Myeloma | 06/25 | 06/26 | | |
NCT04831138: Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Metastatic Renal Cell Carcinoma |
|
|
| Enrolling by invitation | N/A | 90 | US | MRI with ASL | University of Texas Southwestern Medical Center | Renal Cell Carcinoma | 03/26 | 03/27 | | |
NCT03922984: Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma |
|
|
| Completed | N/A | 43 | US | MRI with Arterial Spin Labeling (ASL) | University of Texas Southwestern Medical Center, National Cancer Institute (NCI) | Glioblastoma | 01/24 | 01/24 | | |
Johnson, Natalie |
| Completed | 3 | 4223 | Europe, US | ABNCoV2, Comirnaty | Bavarian Nordic | COVID-19 Disease | 03/23 | 10/23 | | |
| Recruiting | N/A | 2000 | Canada, US | | Biodesix, Inc. | Nodule Solitary Pulmonary, Non-small Cell Carcinoma | 12/24 | 12/26 | | |
| Recruiting | N/A | 500 | Canada, US | | CareDx | Lung Transplant Infection, Lung Transplant; Complications, Lung Transplant Failure and Rejection | 12/28 | 12/28 | | |
Polanco, Patricio |
DIRECT, NCT03899636: A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer |
|
|
| Recruiting | 3 | 528 | US | Modified FOLFIRINOX Regimen, NanoKnife System | Angiodynamics, Inc. | Stage III Pancreatic Cancer | 12/23 | 12/23 | | |
A021806, NCT04340141: Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer |
|
|
| Recruiting | 3 | 352 | Canada, US | Oxaliplatin, Irinotecan Hydrochloride, Leucovorin Calcium, Fluorouracil, Resection, Questionnaire Administration | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI) | Pancreatic Adenosquamous Carcinoma, Resectable Pancreatic Adenocarcinoma, Pancreatic Cancer | 01/26 | 11/30 | | |
| Recruiting | N/A | 4606 | Canada, US, RoW | Computed Tomography, CAT, CAT scan, Computerized Axial Tomography, computerized tomography, CT, CT scan, tomography, Endoscopic Ultrasound, endosonography, EUS, Magnetic Resonance Imaging, Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR Imaging, MRI, MRI Scan, NMR Imaging, NMRI, nuclear magnetic resonance imaging, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration | ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI) | Pancreatic Carcinoma | 07/33 | 07/33 | | |
Shabbir, Misbah |
DIRECT, NCT03899636: A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer |
|
|
| Recruiting | 3 | 528 | US | Modified FOLFIRINOX Regimen, NanoKnife System | Angiodynamics, Inc. | Stage III Pancreatic Cancer | 12/23 | 12/23 | | |
NCT04803058: A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE) |
|
|
| Recruiting | 2 | 18 | US, RoW | TCD601 | ITB-Med LLC | Kidney Transplantation | 03/27 | 03/30 | | |
Batlivala, Sarosh Shawn |
| Recruiting | N/A | 20 | US | Pressure-volume loop catheter | University of Minnesota | Coarctation of Aorta | 12/26 | 12/26 | | |
| Recruiting | N/A | 500 | US | | Kiniksa Pharmaceuticals International, plc, Kiniksa Pharmaceuticals (UK), Ltd. | Recurrent Pericarditis | 02/26 | 02/26 | | |
Johnson, Dena |
| Completed | N/A | 956 | US | Parental Status | University of Pittsburgh, Cystic Fibrosis Foundation, National Heart, Lung, and Blood Institute (NHLBI) | Cystic Fibrosis, Parenthood Status | 08/24 | 08/24 | | |
| Recruiting | N/A | 146 | US | Parenthood | University of Pittsburgh, Cystic Fibrosis Foundation, National Heart, Lung, and Blood Institute (NHLBI) | Cystic Fibrosis, Parenthood Status | 02/30 | 02/31 | | |
Rosenbluth, Daniel |
NCT05641298: Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations |
|
|
| Withdrawn | 2 | 80 | US | Sodium Fusidate, ACG-701, ARV-1801, Placebo | Aceragen | Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | 09/23 | 09/23 | | |
NCT06016088: A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection |
|
|
| Recruiting | 1/2 | 72 | US, RoW | RSP-1502, Tobramycin inhalation solution | Respirion Pharmaceuticals Pty Ltd | Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa | 12/25 | 12/25 | | |
| Recruiting | N/A | 146 | US | Parenthood | University of Pittsburgh, Cystic Fibrosis Foundation, National Heart, Lung, and Blood Institute (NHLBI) | Cystic Fibrosis, Parenthood Status | 02/30 | 02/31 | | |
| Active, not recruiting | N/A | 350 | US | Stool tests, Stool-based Fecal Immunochemical Testing (FIT) test and Stool-based DNA test (Cologuard) test. | University of Washington, the Collaborative Health Studies Coordinating Center, Cystic Fibrosis Foundation | Cystic Fibrosis, Colorectal Cancer, Adenoma | 03/25 | 06/25 | | |
Robles, Elizabeth |
| Recruiting | N/A | 1200 | Canada, US | Kidney Biopsy | University of Michigan, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The NephCure Foundation | Minimal Change Disease (MCD), Membranous Nephropathy, Glomerulosclerosis, Focal Segmental | 06/26 | 06/26 | | |